Molecular Characterization and Antimicrobial Resistance of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Isolates from Pigs and Swine Workers in Central Thailand

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Pattrarat ChanchaithongNuvee Prapasarakul

Abstract

This study presents molecular characteristics of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) from pigs and swine workers in central Thailand. Sixty-three MRSA isolates were recovered from pigs (n = 60) and humans (n = 3). Two major LA-MRSA lineages, including sequence type (ST) 398 and clonal complex 9 (ST9 and ST4576, a novel single-locus variant of ST9), were identified. ST398 had spa type t034 (n = 55). ST9 and ST4576 had t337 (n = 8) and carried staphylococcal cassette chromosome mec (SCCmec) IX only. MRSA-ST398-t034 contained various SCCmec, including SCCmec V (n = 42), a novel SCCmec composite island (n = 12), and a nontypeable SCCmec (n = 1). All isolates were multidrug resistant and carried common resistance genes found in LA-MRSA. This is the first report of the presence of swine MRSA ST398 and multidrug resistance gene cfr in MRSA ST9 in Thailand. With identical molecular characteristics, pigs could be a source of MRSA ST398 spread to humans. A minor variation of genetic features and resistance gene carriage in both lineages represented a heterogeneous population and evolution of the endemic clones. A monitoring program and farm management, with prudent antimicrobial uses, should be impl...Continue Reading

References

Oct 19, 1999·Journal of Clinical Microbiology·B ShopsinB N Kreiswirth
Feb 6, 2004·Journal of Bacteriology·D Ashley Robinson, Mark C Enright
May 6, 2005·Journal of Clinical Microbiology·Vincent PerretenJoachim Frey
Oct 9, 2009·Journal of Clinical Microbiology·Vasanthakumari NeelaEhsanollah Ghaznavi Rad
Dec 8, 2009·Emerging Infectious Diseases·Luca GuardabassiMaureen Boost
Jan 8, 2010·Journal of Clinical Microbiology·Takashi SasakiKeiichi Hiramatsu
Feb 19, 2010·The Journal of Antimicrobial Chemotherapy·Andrea FesslerStefan Schwarz
Nov 16, 2010·Preventive Veterinary Medicine·E M BroensM C M de Jong
May 10, 2011·International Journal of Antimicrobial Agents·Usanee AnukoolElizabeth M H Wellington
Sep 9, 2011·Veterinary Microbiology·Suk-Kyung LimHyo-Sun Kwak
Oct 11, 2011·International Journal of Medical Microbiology : IJMM·Haitske GravelandJaap A Wagenaar
Mar 1, 2012·PloS One·Jesper LarsenRobert L Skov
Mar 6, 2012·Veterinary Microbiology·Anika FrieseUwe Roesler
Apr 19, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K KadlecS Schwarz
May 23, 2012·BMC Veterinary Research·Els M BroensArjen W Van De Giessen
Nov 28, 2012·Japanese Journal of Infectious Diseases·Tetsuo AsaiYutaka Tamura
May 15, 2013·BMC Infectious Diseases·Aroonlug LulitanondKeiichi Hiramatsu
Dec 18, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keith A Rodvold, Kevin W McConeghy
Jun 25, 2014·Current Opinion in Microbiology·Mary D Barton
Jan 17, 2015·International Journal of Antimicrobial Agents·Yu-Yu Chuang, Yhu-Chering Huang
Jan 1, 2015·Antibiotics·Christiane CunyWolfgang Witte
Feb 6, 2017·PloS One·Aneta MroczkowskaJoanna Empel

❮ Previous
Next ❯

Datasets Mentioned

BETA
IBC1631037

Methods Mentioned

BETA
genotyping
PCR
electrophoresis
phosphotransferase

Software Mentioned

Gene Directory

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.